Related Experiment Video
Updated: Jul 16, 2025

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
Published on: December 13, 2019
Adequacy of Size Matching With Predicted Heart Mass Ratio in Diverse Types of Cardiomyopathies
Roh Yanagida1, Ahad Firoz2, Mohammed Kashem1
1Division of Cardiovascular Surgery, Department of Surgery, Temple University Hospital, Philadelphia, PA.
Insights
Predicted heart mass ratio (PHMr) size matching for donor hearts is not uniform across all cardiomyopathies. Undersized hearts decreased survival in dilated and valvular disease, but not hypertrophic, restrictive, or congenital heart disease.
Area of Science:
- Cardiology
- Transplantation Medicine
- Medical Statistics
Background:
- Predicted heart mass ratio (PHMr) is a proposed metric for donor heart size selection.
- The uniform applicability of PHMr across different cardiomyopathy etiologies remains unconfirmed.
Purpose of the Study:
- To investigate whether size matching criteria based on PHMr impacts survival outcomes uniformly across diverse cardiomyopathy types in heart transplant recipients.
- To identify specific cardiomyopathy groups where PHMr-based size matching is less critical for survival.
Main Methods:
- Analysis of the United Network for Organ Sharing registry database (1987-2021) including 53,573 heart transplant recipients.
- Categorization of recipients into six cardiomyopathy groups: dilated, coronary artery disease, hypertrophic, restrictive, valvular, and adult congenital heart disease.
- Stratification of patients by PHMr into five size categories (severely undersized to severely oversized) to assess survival and cause of death.
Main Results:
- Recipients with dilated and valvular cardiomyopathy receiving undersized hearts (PHMr <0.86) exhibited decreased survival compared to size-matched controls.
- Survival outcomes for patients with hypertrophic, restrictive cardiomyopathy, or adult congenital heart disease were not significantly affected by size matching based on PHMr.
- Hazard ratios indicated significant survival decrements for undersized hearts in dilated (1.17, p=0.001) and valvular (1.79, p=0.032) cardiomyopathies.
Conclusions:
- The effectiveness of PHMr for donor heart size matching is not uniform across all cardiomyopathy etiologies.
- Current size matching criteria may be overly restrictive for certain conditions.
- Findings suggest increased donor heart acceptance rates are possible for patients with hypertrophic, restrictive cardiomyopathy, and congenital heart disease where size matching is less critical for survival.
Abstract:
Predicted heart mass ratio (PHMr) has been proposed as an optimal size metric in the selection of a donor heart for transplant; however, it is not known if the same size matching criteria pertains uniformly to all types of cardiomyopathies. Heart transplant recipients in the United Network for Organ Sharing registry database were categorized into 6 groups based on the type of cardiomyopathy, dilated, coronary artery disease, hypertrophic, restrictive, valvular and adult congenital heart disease. Patients in each group of etiology were stratified based on the PHMr into 5 groups: severely undersized <0.86, moderately undersized 0.86 to 0.94, matched 0.95 to 1.04, moderately oversized 1.05 to 1.24, and severely oversized >1.25. The survival and cause of death of patients in each etiology group were reviewed. The United Network for Organ Sharing registry database from January 1987 to July 2021 included 53,573 patients who received a heart transplant. Compared with patients with size matched hearts, recipients with dilated (hazard ratio 1.17, p = 0.001) and valvular (hazard ratio 1.79, p = 0.032) cardiomyopathy who had an undersized heart with PHMr <0.86 had decreased survival. In addition, the survival of patients with hypertrophic or restrictive cardiomyopathy and adult congenital heart disease was not affected by size matching based on the PHMr (0.601 and 0.079, respectively, p = 0.873). In conclusion, our analysis suggests that the size matching criteria based on PHMr may not be uniform to all patients across various etiologies of cardiomyopathy. Therefore, the data can be used to increase the acceptance rate of donor hearts, particularly, for patients with hypertrophic, restrictive cardiomyopathy and congenital heart disease in which size matching is less significant for survival outcome.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy IV: Restrictive Cardiomyopathy

